Catalog NumberSizePrice (USD)Shopping Cart
MO15078100 ug$255.00Buy Now | Add to Cart
Type: Mouse IgG
Applications: IHC; WB
E=ELISA; FACS; FC=Flow Cytometry; FPLC=Fast Protein Liquid Chromatography; GF=Gravity Flow; HPLC=High Performance Liquid Chromatography; ICC=Immunocytochemistry; IF=Immunofluorescence; IHC=Immunohistochemistry; IP=Immunoprecipitation; NAC=Non-adherent Cell Assays; NB=Neutralization of Bioactivity; SE=Sandwich ELISA; TPE=Targeted Protein Expression; WB=Western blotting; ; AC=Adherent Cell Assays; FM=Fluorescent Micsroscopy; ; ; BSC-CM5= Biacore Sensor Chip CM5; BSM=Biosactive Small Molecule or Peptide; CDM=Cell Differentiation Media; ; ; ; ; ; Health and Fitness; ; ; DNA Extraction/Purification; ; In vivo Like Assays
Species Reactivity: H
B=Bovine; Ca=Cat; Ch=Chicken; D=Dog; EQ=Equine; GP=Guinea Pig; H=Human; M=Mouse; P=Porcine; Pr=Primate; R=Rat; Rb=Rabbit; Y=Yeast; Xe=Xenopus; Ze=Zebrafish; ; ; ; NA-Not Applicable; STP=Step-Tactin Proteins; All
Format: Protein G Purified - liquid
Immunogen: Hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, E. coli-derived, recombinant human High Temperature Requirement Protein-2 (rhOmi/HtrA2;aa 134 - 458) with a carboxylterminal six histidine tag (GenBank accession # AF141305).

The mammalian serine protease Omi (also known as HtrA2), was identified as a 49 kDa serine protease, homologous to the bacterial endoprotease HtrA (high-temperature requirement). It is a homotrimeric serine protease that localizes to the mitochondria and is processed to expose an N-terminal reaper-like motif similar to SMAC/Diablo. Omi/HTRA2 is released from the mitochondria in response to apoptotic insult and can interact with the BIR2 or BIR3 domains of XIAP to relieve caspase-IAP inhibition.

It is suspected to play a role in Parkinson's, Alzheimer's, Diabetes and certain forms of cancer.

Image: Detection of HtrA2/Omi with MAB1458.Lysates of human SK-MEL-28, MCF-7, HEK293 and HeLa cells were resolved by SDS-PAGE, transferred to Immobilon-P membrane and immunoblotted with 1.0 g/mL monoclonal anti-HtrA2/Omi, as described in Protocols for Immunoblotting. A 45 second exposure to film is shown


Other Reagents to Consider:


Neurodegenerative Disease

Diabetes and Obesity